Behandlung der Purpura-Schönlein-Henoch-Nephritis bei Kindern und Jugendlichen

Andersen R, Rubak S, Rittig S (2008) Early high-dose immunosuppressive therapy in Henoch-Schonlein purpura nephrotic syndrome may be associated with improved long-term outcome. Pediatr Nephrol 23:1708

Andreoli SP, Bergstein JM (1989) Treatment of severe IgA nephropathy in children. Pediatr Nephrol 3:248–253

Ballardie FW, Roberts IS (2002) Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy. J Am Soc Nephrol 13:142–148

Blumenfeld Z, Mischari O, Schultz N et al (2011) Gonadotropin releasing hormone agonists may minimize cyclophosphamide associated gonadotoxicity in SLE and autoimmune diseases. Semin Arthritis Rheum 41:346–352

Calvino MC, Llorca J, Garcia-Porrua C et al (2001) Henoch-Schonlein purpura in children from northwestern Spain – a 20-year epidemiologic and clinical study. Medicine 80:279–290

Cattran DC, Coppo R, Cook HT et al (2009) The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int 76:534–545

Cheng J, Zhang W, Zhang XH et al (2009) ACEI/ARB therapy for IgA nephropathy: a meta analysis of randomised controlled trials. Int J Clin Pract 63:880–888

Cheng J, Zhang X, Zhang W et al (2009) Efficacy and safety of glucocorticoids therapy for IgA nephropathy: a meta-analysis of randomized controlled trials. Am J Nephrol 30:315–322

Cheng J, Zhang X, Tian J et al (2012) Combination therapy an ACE inhibitor and an angiotensin receptor blocker for IgA nephropathy: a meta-analysis. Int J Clin Pract 66:917–923

Coppo R, Peruzzi L, Amore A et al (2007) IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria. J Am Soc Nephrol 18:1880–1888

Counahan R, Winterborn MH, White RH et al (1977) Prognosis of Henoch-Schonlein nephritis in children. BMJ 2:11–14

Davin JC, Berge IJ ten, Weening JJ (2001) What is the difference between IgA nephropathy and Henoch-Schonlein purpura nephritis? Kidney Int 59:823–834

Donnithorne KJ, Atkinson TP, Hinze CH et al (2009) Rituximab therapy for severe refractory chronic Henoch-Schonlein purpura. J Pediatr 155:136–139

Du Y, Hou L, Zhao C et al (2012) Treatment of children with Henoch-Schonlein purpura nephritis with mycophenolate mofetil. Pediatr Nephrol 27:765–771

Foster BJ, Bernard C, Drummond KN, Sharma AK (2000) Effective therapy for severe Henoch-Schonlein purpura nephritis with prednisone and azathioprine: a clinical and histopathologic study. J Pediatr 136:370–375

Goldstein AR, White RHR, Akuse R, Chantler C (1992) Long-term follow-up of childhood Henoch-Schonlein nephritis. Lancet 339:280–282

Hattori M, Ito K, Konomoto T et al (1999) Plasmapheresis as the sole therapy for rapidly progressive Henoch-Schonlein purpura nephritis in children. Am J Kidney Dis 33:427–433

Hospach T, Klaus G, Holl-Ulrich K et al (2008) Purpura Schoenlein-Henoch: results of the Worlitz 2005 Consensus Conference focusing on diagnosis and therapy. Klin Padiatr 220:47–52

Iijima K, Ito-Kariya S, Nakamura H, Yoshikawa N (1998) Multiple combined therapy for severe Henoch-Schonlein nephritis in children. Pediatr Nephrol 12:244–248

Jauhola O, Ronkainen J, Autio-Harmainen H et al (2011) Cyclosporine A vs. methylprednisolone for Henoch-Schonlein nephritis: a randomized trial. Pediatr Nephrol 26:2159–2166

Kawasaki Y, Suzuki J, Nozawa R et al (2003) Efficacy of methylprednisolone and urokinase pulse therapy for severe Henoch-Schonlein nephritis. Pediatrics 111:785–789

Kawasaki Y, Suzuki J, Sakai N et al (2003) Clinical and pathological features of children with Henoch-Schoenlein purpura nephritis: risk factors associated with poor prognosis. Clin Nephrol 60:153–160

Kawasaki Y, Suzuki J, Suzuki H (2004) Efficacy of methylprednisolone and urokinase pulse therapy combined with or without cyclophosphamide in severe Henoch-Schoenlein nephritis: a clinical and histopathological study. Nephrol Dial Transplant 19:858–864

Lau KK, Wyatt RJ, Moldoveanu Z et al (2007) Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schonlein purpura. Pediatr Nephrol 22:2067–2072

Niaudet P, Habib R (1998) Methylprednisolone pulse therapy in the treatment of severe forms of Schonlein-Henoch purpura nephritis. Pediatr Nephrol 12:238–243

Oner A, Tinaztepe K, Erdogan O (1995) The effect of triple therapy on rapidly progressive type of Henoch-Schonlein nephritis. Pediatr Nephrol 9:6–10

Ozen S, Ruperto N, Dillon MJ et al (2006) EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 65:936–941

Pillebout E, Rocha F, Fardet L et al (2011) Successful outcome using rituximab as the only immunomodulation in Henoch-Schonlein purpura: case report. Nephrol Dial Transplant 26:2044–2046

Pozzi C, Andrulli S, Del Vecchio L et al (2004) Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial. J Am Soc Nephrol 15:157–163

Ren P, Han F, Chen L et al (2012) The combination of mycophenolate mofetil with corticosteroids induces remission of Henoch-Schonlein purpura nephritis. Am J Nephrol 36:271–277

Roberts IS, Cook HT, Troyanov S et al (2009) The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int 76:546–556

Ronkainen J, Nuutinen M, Koskimies O (2002) The adult kidney 24 years after childhood Henoch-Schonlein purpura: a retrospective cohort study. Lancet 360:666–670

Ronkainen J, Ala-Houhala M, Huttunen NP et al (2003) Outcome of Henoch-Schoenlein nephritis with nephrotic-range proteinuria. Clin Nephrol 60:80–84

Ronkainen J, Autio-Harmainen H, Nuutinen M (2003) Cyclosporin A for the treatment of severe Henoch-Schonlein glomerulonephritis. Pediatr Nephrol 18:1138–1142

Scharer K, Krmar R, Querfeld U et al (1999) Clinical outcome of Schonlein-Henoch purpura nephritis in children. Pediatr Nephrol 13:816–823

Shenoy M, Ognjanovic MV, Coulthard MG (2007) Treating severe Henoch-Schonlein and IgA nephritis with plasmapheresis alone. Pediatr Nephrol 22:1167–1171

Shin JI, Park JM, Shin YH et al (2005) Can azathioprine and steroids alter the progression of severe Henoch-Schonlein nephritis in children? Pediatr Nephrol 20:1087–1092

Soares PM, Borba EF, Bonfa E et al (2007) Gonad evaluation in male systemic lupus erythematosus. Arthritis Rheum 56:2352–2361

Somers EC, Marder W, Christman GM et al (2005) Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus. Arthritis Rheum 52:2761–2767

Suzuki H, Kiryluk K, Novak J et al (2011) The pathophysiology of IgA nephropathy. J Am Soc Nephrol 22:1795–1803

Tanaka H, Suzuki K, Nakahata T et al (2003) Early treatment with oral immunosuppressants in severe proteinuric purpura nephritis. Pediatr Nephrol 18:347–350

Tarshish P, Bernstein J, Edelmann CM (2004) Henoch-Schonlein purpura nephritis: course of disease and efficacy of cyclophosphamide. Pediatr Nephrol 19:51–56

Tumlin JA, Lohavichan V, Hennigar R (2003) Crescentic, proliferative IgA nephropathy: clinical and histological response to methylprednisolone and intravenous cyclophosphamide. Nephrol Dial Transplant 18:1321–1329

Xu G, Tu W, Jiang D, Xu C (2009) Mycophenolate mofetil treatment for IgA nephropathy: a meta-analysis. Am J Nephrol 29:362–367

Yoshikawa N, Honda M, Iijima K et al (2006) Steroid treatment for severe childhood IgA nephropathy: a randomized, controlled trial. Clin J Am Soc Nephrol 1:511–517